Metabolomic analysis of acetaminophen induced subclinical liver injury

References

• Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364–1372.
   PubMed Web of Science ®Google Scholar
• Russo MW, Galanko JA, Shrestha R, et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10(8):1018–1023.
   PubMed Web of Science ®Google Scholar
• Alhelail MA, Hoppe JA, Rhyee SH, et al. Clinical course of repeated supratherapeutic ingestion of acetaminophen. Clin Toxicol. 2011;49(2):108–112.
   Web of Science ®Google Scholar
• Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006;296(1):87–93.
   PubMed Web of Science ®Google Scholar
• Winnike JH, Li Z, Wright FA, et al. Use of Pharmaco-metabonomics for early prediction of Acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther. 2010;88(1):45–51.
   PubMed Web of Science ®Google Scholar
• Chen W, Koenigs LL, Thompson SJ, et al. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol. 1998;11(4):295–301.
   PubMed Web of Science ®Google Scholar
• Patten CJ, Thomas PE, Guy RL, et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol. 1993;6(4):511–518.
   PubMed Web of Science ®Google Scholar
• Raucy JL, Lasker JM, Lieber CS, et al. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys. 1989;271(1):270–283.
   PubMedGoogle Scholar
• Thummel KE, Lee CA, Kunze KL, et al. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by Human CYP3A4. Biochem Pharmacol. 1993;45(8):1563–1569.
   PubMed Web of Science ®Google Scholar
• Dahlin DC, Miwa GT, Lu AY, et al. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci. 1984;81(5):1327–1331.
   PubMed Web of Science ®Google Scholar
• Potter W, Thorgeirsson S, Jollow D, et al. Acetaminophen-induced hepatic necrosis V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology. 1974;12(3):129–143.
   PubMed Web of Science ®Google Scholar
• Salminen WF, Roberts SM, Pumford NR, et al. Immunochemical comparison of 3'-hydroxyacetanilide and acetaminophen binding in mouse liver. Drug Metab Dispos. 1998;26(3):267–271.
   PubMed Web of Science ®Google Scholar
• Chen C, Krausz KW, Idle JR, et al. Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. J Biol Chem. 2008;283(8):4543–4559.
   PubMed Web of Science ®Google Scholar
• Ganetsky M, Böhlke M, Pereira L, et al. Effect of excipients on acetaminophen metabolism and its implications for prevention of liver injury: the journal of clinical pharmacology. J Clin Pharmacol. 2013;53(4):413–420.
   PubMed Web of Science ®Google Scholar
• Kelava T, Ćavar I, Čulo F. Influence of small doses of various drug vehicles on acetaminophen-induced liver injury. Can J Physiol Pharmacol. 2010;88(10):960–967.
   PubMed Web of Science ®Google Scholar
• Thomsen MS, Loft S, Roberts DW, et al. Cytochrome P4502E1 inhibition by propylene glycol prevents acetaminophen (paracetamol) hepatotoxicity in mice without cytochrome P4501A2 inhibition. Basic Clin Pharmacol Toxicol. 1995;76(6):395–399.
   Google Scholar
• Rumack BH. Acetaminophen overdose in young children: treatment and effects of alcohol and other additional ingestants in 417 cases. Am J Dis Child. 1984;138(5):428–433.
   PubMedGoogle Scholar
• Ganetsky M, Anders BH, Solano JJ, et al. Inhibition of CYP2E1 with propylene glycol does not protect against hepatocellular injury in human acetaminophen Daily-Dosing model. J Clin Pharmacol. 2019;59(1):131–138.
   PubMed Web of Science ®Google Scholar
• Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends. Proteomics. 2006;6(17):4716–4723.
   PubMed Web of Science ®Google Scholar
• Hiltunen TP, Rimpelä JM, Mohney RP, et al. Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension. PLoS One. 2017;12(11):e0187729.
   PubMed Web of Science ®Google Scholar
• Heard K, Green JL, Anderson V, et al. A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration. BMC Pharmacol Toxicol. 2014;15(1):39.
   PubMedGoogle Scholar
• Dart RC, Bailey E. Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy. 2007;27(9):1219–1230.
   PubMed Web of Science ®Google Scholar
• Lee WM. Acetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away? J Hepatol. 2017;67(6):1324–1331.
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Jaeschke H. Acetaminophen hepatotoxicity. Semin Liver Dis. 2019;39(2):221–234.
   PubMed Web of Science ®Google Scholar
• Vickers A. Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors. Toxicol Pathol. 2009;37(1):78–88.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Pence L, Beger R, et al. Acylcarnitine profiles in acetaminophen toxicity in the mouse: comparison to toxicity, metabolism and hepatocyte regeneration. Metabolites. 2013;3(3):606–622.
   PubMedGoogle Scholar
• Chen C, Krausz KW, Shah YM, et al. Serum metabolomics reveals irreversible inhibition of fatty acid β-Oxidation through the suppression of PPARα activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem Res Toxicol. 2009;22(4):699–707.
   PubMed Web of Science ®Google Scholar
• Patterson AD, Shah YM, Matsubara T, et al. Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity. Hepatology. 2012;56(1):281–290.
   PubMed Web of Science ®Google Scholar
• McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 2013;30(9):2174–2187.
   PubMed Web of Science ®Google Scholar
• Reiter C, Weinshilboum R. Acetaminophen and phenol: substrates for both a thermostable and a thermolabile form of human platelet phenol sulfotransferase. J Pharmacol Exp Ther. 1982;221(1):43–51.
   PubMed Web of Science ®Google Scholar
• Cohen IV, Cirulli ET, Mitchell MW, et al. Acetaminophen (Paracetamol) use modifies the sulfation of sex hormones. EBioMedicine. 2018;28:316–323.
   PubMed Web of Science ®Google Scholar
• Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313.
   PubMed Web of Science ®Google Scholar
• Avella-Garcia CB, Julvez J, Fortuny J, et al. Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms. Int J Epidemiol. 2016;45(6):1987–1996.
   PubMed Web of Science ®Google Scholar
• Stergiakouli E, Thapar A, Davey Smith G. Association of acetaminophen use during pregnancy with behavioral problems in childhood: evidence against confounding. JAMA Pediatr. 2016;170(10):964.
   PubMed Web of Science ®Google Scholar
• Thompson JMD, Waldie KE, Wall CR, the ABC Study Group, et al. Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One. 2014;9(9):e108210.
   PubMed Web of Science ®Google Scholar
• Masarwa R, Levine H, Gorelik E, et al. Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: a systematic review, Meta-Analysis, and Meta-Regression analysis of cohort studies. Am J Epidemiol. 2018;187(8):1817–1827.
   PubMed Web of Science ®Google Scholar